Week 7 L1 biomed application, antimicrobial resistance Flashcards
1
Q
The definition of infectious disease
A
- Harmful effects of one organism (‘pathogen’) on another organism (‘host’) in or on which they replicate
- Pathogens can transfer between hosts across or (more commonly) within species
2
Q
Penicillin use in the beginning
A
- Penicillin, part of the larger β-lactam group, showed immediate promise, but scaling up production was a challenge
- By 1944, Australia produced enough penicillin to allow some civilian use
3
Q
Antimicrobial resistance evolution: why did it happen?
A
- Individuals belonging to a given species of pathogen will vary genetically in numerous ways; this may include toxin resistance
- Use of antimicrobials creates a selective pressure favouring survival and reproduction of the most resistant individuals
- Over time, this will drive up the dose of an antimicrobial needed to clear an infection (minimum inhibitory concentration), or perhaps make it entirely ineffective
4
Q
mechanism of penicillin
A
- Penicillin mimics the structure of peptidoglycan, blocking the activity of enzymes which connect peptidoglycan molecules
- Penicillin uptake is affected by cell wall structure - the outer membrane of Gram-negative bacteria (e.g. E. coli) mostly blocks movement, but pores within it allow access
5
Q
Mechanism of penicillin resistance
A
- Three main mechanisms of penicillin resistance are known
- Target site alteration; some peptidoglycan-synthesis enzymes show much weaker binding to penicillin
- Reduced (net) uptake; higher levels of cell membrane proteins which remove penicillin from the cell increase resistance
- Degradation; β-lactamases break the β-lactam ring
6
Q
The origins of penicillin resistance
A
- Many bacteria had resistance to penicillin due to contact with Penicillum fungus
- The spread of resistance into previously susceptible species is promoted by the capacity for bacteria to exchange genetic material, e.g. through plasmids
7
Q
Bacterial plasmid exchange
A
- Plasmids carrying TEM-1 β-lactamase were first identified in E. coli and Salmonella species in the mid-1960s
- A decade later, they had also been found in Pseudomonas aeruginosa, Vibrio cholerae, Haemophilus species and Neisseria species
8
Q
The proliferation of antimicrobials
A
- Penicillin resistance spurred the development of alternative antimicrobials, often with naturally-occurring products as a start point
- Major antibacterial groups include:
- Diaminopyrimidines, quinolones (introduced in 1962) and sulfonamides (1935) - block DNA replication
- Aminoglycosides (1946), macrolides (1952) and lincosamides (1953) - inhibit protein synthesis
- Quinolones (1962) - block DNA unwinding and duplication
- Tetracyclines (1948) - inhibit protein synthesis or disrupt cell wall
9
Q
Novel antimicrobials, similar resistance
mechanisms
A
- Sulfonamides, an antimicrobial are now rarely used, in part due to the prevalence of mutations in their target, dihydropteroate synthase
- Aminoglycoside resistance largely occurs through enzymes which add functional groups to the antibiotics
- Efflux pumps play an important role in quinolone resistance in some bacteria
10
Q
The downsides of resistance to the microbe itself
A
- Mutations affecting an antimicrobial target protein are likely to reduce its activity
- However, plasmids can introduce an ‘alternative’ resistant form while leaving the native protein intact
- Expressing high levels of transport proteins or enzymes which metabolise antimicrobials may cause direct harms as well as requiring energy
11
Q
Slowing resistance development in microbes
A
- Removing an antibiotic from use may lead to loss of resistance over time - reducing use in agriculture is a popular goal
- Combination therapy can make formation of resistance less likely, especially where different mechanisms of resistance to each agent are favoured
- Specific common resistance mechanisms can be directly countered, e.g. βlactamase inhibitors, efflux inhibitors
12
Q
Antibiotic dosing
A
- The relationship between antibiotic concentration and level of resistance is affected by many factors
- Greater levels of antibiotic use will cause more intensive selection for resistance in commensal bacteria
13
Q
Antibiotic persistence
A
- In numerous populations of genetically identical bacteria, variation in lethality of a given antibiotic dose has been observed
- Under environmental stress, a portion of bacterial cells will enter metabolic dormancy, suspending many of the processes targeted by antibiotics
- Persistence is particularly common within biofilms
14
Q
Alternative treatments For microbe
A
- Antimicrobial development has slowed greatly - fewer than 50 candidate antibiotics in 2015, vs. more than 800 anti-cancer drugs
- Alternatives - or adjuncts - to antimicrobials could be considered
- Vaccines against several bacteria exist, with others in development
- Bacteriophages - viruses which infect bacteria -may be particularly useful in combatting biofilms